Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Avotaciclib (BEY1107) is a potent and orally active cyclin dependent kinase 1 (CDK1) inhibitor.Avotaciclib can be used to study locally advanced or metastatic pancreatic cancer.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 27,500 | |||
5 mg | 在庫あり | ¥ 66,000 | |||
10 mg | 在庫あり | ¥ 105,000 | |||
25 mg | 在庫あり | ¥ 172,000 | |||
50 mg | 在庫あり | ¥ 243,500 | |||
100 mg | 在庫あり | ¥ 326,000 | |||
500 mg | 在庫あり | ¥ 654,000 |
説明 | Avotaciclib (BEY1107) is a potent and orally active cyclin dependent kinase 1 (CDK1) inhibitor.Avotaciclib can be used to study locally advanced or metastatic pancreatic cancer. |
別名 | BEY1107, Avotaciclib |
分子量 | 281.27 |
分子式 | C13H11N7O |
CAS No. | 1983983-41-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (177.77 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Avotaciclib 1983983-41-0 Cell Cycle/Checkpoint CDK BEY1107 BEY-1107 BEY 1107 Inhibitor inhibitor inhibit